Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3Unknown 2Terminated 1Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Depression 3Breast Neoplasms 3Brain Neoplasms 3Anxiety Disorders 3Pain, Postoperative 2Urinary Bladder Neoplasms 1Stroke 1Prostatic Neoplasms 1Pain 1Ovarian Neoplasms 1Meningioma 1Erectile Dysfunction 1Emergence Delirium 1Delirium 1Carcinoma, Renal Cell 1Agnosia 1Advanced Ovarian Cancer 1

Interventions

Paclitaxel 9Carboplatin 8Bevacizumab 8fluzoparib 5olaparib 3Topotecan 3Gemcitabine 3liposomal doxorubicin 2famitinib 2apatinib 2Oxaliplatin 2Magnetic Resonance Spectroscopy 2Indocyanine Green 2Drug Therapy 2Cisplatin 2trametinib 1senaparib 1pembrolizumab 1niraparib 1montelukast 1irinotecan sucrosofate 1fludarabine 1durvalumab 1dalpiciclib 1dabrafenib 1ceralasertib 1anlotinib 1aldesleukin 1Ultrasonography, Doppler 1Therapeutics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Ovarian Neoplasms × Saline Solution × Clear all
NCT05450055 2022-07-13

Intraperitoneal Lidocaine in Ovarian Cancer Surgery

Peking University Third Hospital

Phase NA Not yet recruiting
60 enrolled
Gynecologic

Ovarian Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡